{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:19:03Z","timestamp":1784859543314,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Keck Graduate Institute"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.075","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T09:02:59Z","timestamp":1445936579000},"page":"6745-6751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Ryan C.","family":"McComb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lee","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence K.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Martchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.075_bib0155","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0165","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell-surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0170","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.1016\/S0021-9258(17)32036-7","article-title":"Anthrax protective antigen forms oligomers during intoxication of mammalian-cells","volume":"269","author":"Milne","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0175","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1073\/pnas.86.7.2209","article-title":"Anthrax toxin channel-forming activity of protective antigen in planar phospholipid-bilayers","volume":"86","author":"Blaustein","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0180","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1365-2958.1991.tb00796.x","article-title":"Anthrax toxin protective antigen\u2014low-pH-induced hydrophobicity and channel formation in liposomes","volume":"5","author":"Koehler","year":"1991","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2958.1993.tb00936.x","article-title":"pH-dependent permeabilization of the plasma-membrane of mammalian-cells","volume":"10","author":"Milne","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0190","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase\u2013kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0195","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0200","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/IAI.74.1.394-398.2006","article-title":"Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume":"74","author":"Weiss","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1586\/14760584.2013.814860","article-title":"Anthrax vaccines: present status and future prospects","volume":"12","author":"Kaur","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0215","series-title":"Approved products\u2014biothrax","author":"CBER","year":"2015"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/653495","article-title":"Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge","volume":"202","author":"Crowe","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0225","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","article-title":"A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo","volume":"264","author":"Singh","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0230","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1073\/pnas.2436299100","article-title":"Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis","volume":"100","author":"Mourez","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0235","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1073\/pnas.062160399","article-title":"Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen","volume":"99","author":"Cunningham","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.7.1.33","article-title":"Genetically engineered Tobacco mosaic virus as nanoparticle vaccines","volume":"7","author":"McCormick","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"Yusibov","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0255","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1104\/pp.107.106377","article-title":"TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector","volume":"145","author":"Lindbo","year":"2007","journal-title":"Plant Physiol"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0260","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1016\/j.vaccine.2006.04.058","article-title":"Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes","volume":"24","author":"Palmer","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.virol.2005.12.039","article-title":"Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications","volume":"348","author":"Smith","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0270","doi-asserted-by":"crossref","first-page":"15583","DOI":"10.1073\/pnas.1010145107","article-title":"Heterodimeric integrin complexes containing beta 1-integrin promote internalization and lethality of anthrax toxin","volume":"107","author":"Martchenko","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0280","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/CVI.00015-08","article-title":"Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background","volume":"15","author":"Abboud","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0285","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1073\/pnas.96.14.7774","article-title":"Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope","volume":"96","author":"Koo","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jmbi.1999.2860","article-title":"Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus\u2013host interactions","volume":"290","author":"Bendahmane","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0295","doi-asserted-by":"crossref","first-page":"e15087","DOI":"10.1371\/journal.pone.0015087","article-title":"An induced hypersensitive-like response limits expression of foreign peptides via a recombinant TMV-based vector in a susceptible tobacco","volume":"5","author":"Li","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.075_bib0300","first-page":"13","article-title":"Display of peptides on the surface of tobacco mosaic virus particles","volume":"vol. 332","author":"Smith","year":"2009"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:24:13Z","timestamp":1653398653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015042"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}